← Leaderboards
Odile David
University Of Illinois At Chicago
$600,918
Attributed
$600,918
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $120.2K · FY2005–09$200K$150K$100K$50K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$600,918 · 1
By mechanism
K23$600,918 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Illinois At Chicago
Same institution · by research overlap
- Sajani Lakka$1,287,462
- Alan Douglas Kinghorn$8,986,673
- Jeffrey A Sosman$7,988,701
- Carol Estwing Ferrans$4,824,952
- Takeshi Shimamura$1,905,724
Others in their field
Top investigators on “Flow Cytometry”
- Peter Gordon Gillespie · Oregon Health And Science University$107,304,619
- Joseph E Robertson · Oregon Health & Science University$60,681,954
- Prasant Mohapatra · University Of California At Davis$53,606,662
- David Heimbrook · Leidos Biomedical Research, Inc.$44,124,630
- Roger Detels · University Of California Los Angeles$40,925,678
- Simon J. Atkinson · University Of California At Davis$35,573,802
Research focus
Flow CytometryBaseEventApoptosisBronchoscopyCancer CellBehaviorEpidermal Growth Factor ReceptorCarcinogenesisApoptoticCareerCell SurvivalCharacteristicsChemotherapeutic AgentChemotherapyCancer Cell LineCancer PatientClinical DataClinical InvestigatorClinical ResearchCohortDiagnosisDiagnosticFollow-Up
Grant awards (5)
Prognostic Significance of Actuvated Akt/PKB in Cancer$120,235
K23 · FY2009 · RR · contact PI
Prognostic Significance of Actuvated Akt/PKB in Cancer$120,232
K23 · FY2008 · RR · contact PI
Prognostic Significance of Actuvated Akt/PKB in Cancer$120,151
K23 · FY2007 · RR · contact PI
Prognostic Significance of Actuvated Akt/PKB in Cancer$120,150
K23 · FY2006 · RR · contact PI
Prognostic Significance of Actuvated Akt/PKB in Cancer$120,150
K23 · FY2005 · RR